SZU

2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide

Created:	2022-12-20
Last modified:	2023-05-15

Find Related PDB Entry
2 entries where SZU is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	51
Chiral Atom Count	0
Bond Count	54
Aromatic Bond Count	21

2D diagram of SZU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide
Systematic Name (OpenEye OEToolkits)	2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide
Formula	C₂₁ H₂₁ F N₆ O₂
Molecular Weight	408.429
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Fc1cccnc1CNC(=O)c2coc(CCNCCc3[nH]c4ccccc4n3)n2
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)[nH]c(n2)CCNCCc3nc(co3)C(=O)NCc4c(cccn4)F
Canonical SMILES	CACTVS	3.385	Fc1cccnc1CNC(=O)c2coc(CCNCCc3[nH]c4ccccc4n3)n2
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)[nH]c(n2)CCNCCc3nc(co3)C(=O)NCc4c(cccn4)F
InChI	InChI	1.06	InChI=1S/C21H21FN6O2/c22-14-4-3-9-24-17(14)12-25-21(29)18-13-30-20(28-18)8-11-23-10-7-19-26-15-5-1-2-6-16(15)27-19/h1-6,9,13,23H,7-8,10-12H2,(H,25,29)(H,26,27)
InChIKey	InChI	1.06	KNYVRFXIVWUGBZ-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB17692
Name	Vamifeport
Groups	investigational
Description	Vamifeport is being investigated for the treatment of beta-thalassemia.
Synonyms	4-oxazolecarboxamide, 2-(2-((2-(1h-benzimidazol-2-yl)ethyl)amino)ethyl)-n-((3-fluoro-2-pyridinyl)methyl)- 2-(2-((2-(1h-benzimidazol-2-yl)ethyl)amino)ethyl)-n-((3-fluoropyridin-2-yl)methyl)-1,3-oxazole-4-carboxamide Vamifeport Vamifeport hydrochloride
Categories	Heterocyclic Compounds, Fused-Ring
CAS number	2095668-10-1

Related Resource References

Resource Name	Reference
PubChem	129052159
ChEMBL	CHEMBL4596566

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.